NCT00959907View on ClinicalTrials.gov

Comparison of Two Commercial Preparations of Botulinum Toxin Type A

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

December 31, 2007

Conditions
Wrinkles in Frontal Area
Interventions
DRUG

BOTULINUM TOXIN TYPE-A

"On Visit 1 (Day 0):~Botulinum toxin A (Dysport® and Botox®) will be administered according to an equivalence ratio of 2:1. Both reconstituted in the same volume per point, injected in the forehead determined site.~* Dysport®: 4 units will be injected in the left or right forehead side.~* Botox® : 2 units will be injected in the left or right forehead side.(opposite side of dysport injection)"

Trial Locations (1)

90570-040

Brazilian Center for Dermatological Studies, Porto Alegre

All Listed Sponsors
lead

Brazilan Center for Studies in Dermatology

OTHER

NCT00959907 - Comparison of Two Commercial Preparations of Botulinum Toxin Type A | Biotech Hunter | Biotech Hunter